Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-05

Clinical Trial Update: Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing insulin NPH to a new insulin formulation in adults with Type 2 diabetes, reporting safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • New insulin formulation
  • insulin NPH (insulin NPH)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED